Table 4 Multivariate analysis of factors for good neurologic outcome at 6 months

First-line immunomodulating treatment

 Early intravenous immunoglobulins

2.26

0.54−9.35

 Early steroids

3.26

0.62–17.19

 Early combined treatment

8.42

2.11–33.57

 Late treatment

1

–

White blood cell count in first CSF (cells/mm³)

 <10

6.88

1.58–29.92

 10–50

3.60

1.03–12.65

 >50

1

–